Clinical Trial: Cardiorenal Syndrome in End-Stage Kidney Disease

Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title:

Brief Summary:

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality.

The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.


Detailed Summary:
Sponsor: Hillel Yaffe Medical Center

Current Primary Outcome: Heart Pathology Identification [ Time Frame: One hour ]

Visual identification of heart pathology in ESRD patients using echocardiography by measuring the ejection fraction of the left-ventricle during the systolic and diastolic phases. Valvular pathology is measured by the size of the valve.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hillel Yaffe Medical Center

Dates:
Date Received: September 10, 2014
Date Started: October 2014
Date Completion: February 2015
Last Updated: September 10, 2014
Last Verified: September 2014